Patents by Inventor Miho Furue

Miho Furue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11222423
    Abstract: An evaluation device includes a state determination unit which is configured to determine a state of cells which are an observation target under non-standard conditions on the basis of information acquired from an image of cells under standard conditions.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: January 11, 2022
    Assignees: Nikon Corporation, National Institutes Of Biomedical Innovation, Health And Nutrition
    Inventors: Hiroaki Kii, Yasujiro Kiyota, Takayuki Uozumi, Miho Furue, Mika Suga
  • Publication number: 20190218514
    Abstract: The present invention provides a method for producing neural stem cells, the method including a culture step of culturing cells using a medium that contains a TGF-? receptor inhibitor and a protein kinase C inhibitor. The method for producing neural stem cells is a method that includes a first culture step of culturing cells using a first medium that does not contain a TGF-? receptor inhibitor and a protein kinase C inhibitor, and a second culture step of culturing the cells using a second medium that contains a TGF-? receptor inhibitor and a protein kinase C inhibitor, after the first culture step. The method for producing neural stem cells is a method that includes a first culture step of culturing cells using a first medium that contains ascorbic acid or an ascorbic acid derivative, and a second culture step of culturing the cells using a second medium that contains a TGF-? receptor inhibitor and a protein kinase C inhibitor, after the first culture step.
    Type: Application
    Filed: May 26, 2017
    Publication date: July 18, 2019
    Inventors: Hiroaki KII, Yasujiro KIYOTA, Takayuki UOZUMI, Miho FURUE, Mika SUGA
  • Publication number: 20190177686
    Abstract: An object of the present invention is to provide an albumin-free medium for serum-free culture of pluripotent stem cells capable of maintaining the undifferentiated state and the pluripotency (pluripotent ability) of the pluripotent stem cells, an additive for an albumin-free medium, and a culture method. The albumin-free medium for serum-free culture of pluripotent stem cells, the additive for an albumin-free medium, and a medium used for the culture method of the invention are characterized by containing at least one selected from the group consisting of a Pluronic nonionic surfactant, an animal-based hydrolysate, and a nonanimal-based hydrolysate.
    Type: Application
    Filed: May 8, 2017
    Publication date: June 13, 2019
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Miho FURUE, Kana YANAGIHARA, Shinichiro SHOJI, Masayoshi TSUKAHARA
  • Publication number: 20190127707
    Abstract: An object of the present invention is to provide a medium for culturing naive pluripotent stem cells which is for efficiently proliferating naive pluripotent stem cells while maintaining the undifferentiated state and the pluripotency (pluripotent capability) of the naive pluripotent stem cells.
    Type: Application
    Filed: March 30, 2017
    Publication date: May 2, 2019
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Miho FURUE, Shinichiro SHOJI, Kana YANAGIHARA, Masayoshi TSUKAHARA
  • Publication number: 20190087956
    Abstract: An evaluation device includes a state determination unit which is configured to determine a state of cells which are an observation target under non-standard conditions on the basis of information acquired from an image of cells under standard conditions.
    Type: Application
    Filed: September 7, 2018
    Publication date: March 21, 2019
    Inventors: Hiroaki KII, Yasujiro KIYOTA, Takayuki UOZUMI, Miho FURUE, Mika SUGA
  • Publication number: 20170009203
    Abstract: Disclosed are: a gene transduction method for use in the induction of the differentiation of stem cells such as ES cells or iPS cells into hepatocytes effectively; stem cells into each of which a gene useful for the induction of the differentiation into hepatocytes is introduced; and hepatocytes produced from stem cells each having the gene introduced therein. A specific gene can be introduced into stem cells such as ES cells or iPS cells using an adenovirus vector. The effective induction of the differentiation into hepatocytes can be achieved by introducing the gene. Specifically, the effective induction of the differentiation of stem cells such as ES cells or iPS cells into hepatocytes can be achieved by introducing at least one gene selected from HEX gene, HNF4A gene, HNF6 gene and SOX17 gene into the stem cells.
    Type: Application
    Filed: September 16, 2016
    Publication date: January 12, 2017
    Applicant: Japan Health Sciences Foundation
    Inventors: Hiroyuki Mizuguchi, Kenji Kawabata, Mitsuru Inamura, Miho Furue
  • Publication number: 20150344567
    Abstract: The present invention provides a monoclonal antibody that recognizes a lipid substance on an iPS cell surface and an ES cell surface as an epitope, and does not recognize EC cells, the antibody having a cytotoxic activity against a target cell, a method of producing a uniform differentiated cell population free of an undifferentiated cell, including contacting a cell population differentiated from an iPS or ES cell with the above antibody, and recovering viable cells, an agent for a cell transplantation therapy, containing a differentiated cell population obtained by the method, and the like.
    Type: Application
    Filed: December 20, 2013
    Publication date: December 3, 2015
    Inventors: Toshisuke KAWASAKI, Nobuko KAWASAKI, Miho FURUE, Kenji KAWABATA, Hidenao TOYODA
  • Publication number: 20130309768
    Abstract: An aim of the present invention is to provide a method for culturing a human pluripotent stem cell while maintaining an undifferentiated state, more efficiently than conventional methods, and a kit therefor. The pluripotency of a stem cell was found to be maintained at a high rate, regardless of experimenter's proficiency in culturing techniques, by (a) culturing a human pluripotent stem cell in a first medium which a medium for pluripotent stem cell comprising activin; (b) replacing the first medium with a second medium which is a medium for pluripotent stem cell comprising no activin, and culturing the human pluripotent stem cell, (c) subculturing the human pluripotent stem cell into the first medium, and then repeating the above (b) and (c) sequentially.
    Type: Application
    Filed: August 24, 2011
    Publication date: November 21, 2013
    Applicant: NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION
    Inventors: Miho Furue, Masaki Kinehara
  • Publication number: 20120231490
    Abstract: Disclosed are: a gene transduction method for use in the induction of the differentiation of stem cells such as ES cells or iPS cells into hepatocytes effectively; stem cells into each of which a gene useful for the induction of the differentiation into hepatocytes is introduced; and hepatocytes produced from stem cells each having the gene introduced therein. A specific gene can be introduced into stem cells such as ES cells or iPS cells using an adenovirus vector. The effective induction of the differentiation into hepatocytes can be achieved by introducing the gene. Specifically, the effective induction of the differentiation of stem cells such as ES cells or iPS cells into hepatocytes can be achieved by introducing at least one gene selected from HEX gene, HNF4A gene, HNF6 gene and SOX17 gene into the stem cells.
    Type: Application
    Filed: October 22, 2010
    Publication date: September 13, 2012
    Applicant: JAPAN HEALTH SCIENCES FOUNDATION
    Inventors: Hiroyuki Mizuguchi, Kenji Kawabata, Mitsuru Inamura, Miho Furue
  • Patent number: 7923245
    Abstract: The present invention discloses a medium for a serum-free medium capable of culturing ES cells for a long period while maintaining their undifferentiated state without using feeder cells, and a basal medium for producing the medium thus described. The basal medium of the present invention is characterized by that it has composition shown by Table I. Further, the present invention discloses a medium for ES cells produced with the basal medium.
    Type: Grant
    Filed: December 27, 2004
    Date of Patent: April 12, 2011
    Inventors: Miho Furue, Tetsuji Okamoto, Makoto Asashima
  • Publication number: 20080050817
    Abstract: The present invention discloses a medium for a serum-free medium capable of culturing ES cells for a long period while maintaining their undifferentiated state without using feeder cells, and a basal medium for producing the medium thus described. The basal medium of the present invention is characterized by that it has composition shown by Table I. Further, the present invention discloses a medium for ES cells produced with the basal medium.
    Type: Application
    Filed: December 27, 2004
    Publication date: February 28, 2008
    Inventors: Miho Furue, Tetsuji Okamoto, Makoto Asashima